Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
2,648
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,471.50 | 18.80 | 0.22% |
CAC 40 | 7,282.69 | 10.37 | 0.14% |
DAX 40 | 19,848.77 | 35.98 | -0.18% |
Dow JONES (US) | 43,297.03 | 390.08 | 0.91% |
FTSE 100 | 8,136.99 | 34.27 | 0.42% |
HKSE | 20,098.29 | 215.16 | 1.08% |
NASDAQ | 20,031.13 | 266.24 | 1.35% |
Nikkei 225 | 39,568.06 | 437.63 | 1.12% |
NZX 50 Index | 13,074.74 | 86.71 | 0.67% |
S&P 500 | 6,040.04 | 65.97 | 1.10% |
S&P/ASX 200 | 8,220.90 | 19.30 | 0.24% |
SSE Composite Index | 3,393.53 | 42.27 | 1.26% |